Education
About Us
Working with TipRanks
Follow Us
Hansoh Pharmaceutical Group Company Limited (HK:3692)
:3692
Total Valuation
Hansoh Pharmaceutical Group Company Limited has a market cap or net worth of HK$210.60B. The enterprise value is HK$147.62B.
Market CapHK$210.60B
Enterprise ValueHK$147.62B
Share Statistics
Hansoh Pharmaceutical Group Company Limited has 6,055,150,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,055,150,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hansoh Pharmaceutical Group Company Limited’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 11.94%.
Return on Equity (ROE)0.15
Return on Assets (ROA)0.14
Return on Invested Capital (ROIC)11.94%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee1.36M
Profits Per Employee486.35K
Employee Count8,989
Asset Turnover0.39
Inventory Turnover1.70
Valuation Ratios
The current PE Ratio of Hansoh Pharmaceutical Group Company Limited is 40.1. Hansoh Pharmaceutical Group Company Limited’s PEG ratio is 0.46.
PE Ratio40.1
PS Ratio7.85
PB Ratio3.36
Price to Fair Value3.36
Price to FCF26.44
Price to Operating Cash Flow175.20
PEG Ratio0.46
Income Statement
In the last 12 months, Hansoh Pharmaceutical Group Company Limited had revenue of 12.26B and earned 4.37B in profits. Earnings per share was 0.74.
Revenue12.26B
Gross Profit11.16B
Operating Income4.03B
Pretax Income5.09B
Net Income4.37B
EBITDA4.28B
Earnings Per Share (EPS)0.74
Cash Flow
In the last 12 months, operating cash flow was 1.18B and capital expenditures -120.12M, giving a free cash flow of 1.06B billion.
Operating Cash Flow1.18B
Free Cash Flow1.06B
Free Cash Flow per Share0.18
Dividends & Yields
Hansoh Pharmaceutical Group Company Limited pays an annual dividend of HK$0.232, resulting in a dividend yield of 1.07%
Dividend Per ShareHK$0.232
Dividend Yield1.07%
Payout Ratio26.12%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.74
52-Week Price Change90.64%
50-Day Moving Average36.18
200-Day Moving Average27.43
Relative Strength Index (RSI)43.04
Average Volume (3m)9.67M
Important Dates
Hansoh Pharmaceutical Group Company Limited upcoming earnings date is Mar 31, 2026, TBA (Confirmed).
Last Earnings DateAug 18, 2025
Next Earnings DateMar 31, 2026
Ex-Dividend DateSep 22, 2025
Financial Position
Hansoh Pharmaceutical Group Company Limited as a current ratio of 10.18, with Debt / Equity ratio of 0.38%
Current Ratio10.18
Quick Ratio9.94
Debt to Market Cap<0.01
Net Debt to EBITDA-5.26
Interest Coverage Ratio602.65
Taxes
In the past 12 months, Hansoh Pharmaceutical Group Company Limited has paid 713.36M in taxes.
Income Tax713.36M
Effective Tax Rate0.14
Enterprise Valuation
Hansoh Pharmaceutical Group Company Limited EV to EBITDA ratio is 17.24, with an EV/FCF ratio of 20.26.
EV to Sales6.01
EV to EBITDA17.24
EV to Free Cash Flow20.26
EV to Operating Cash Flow19.09
Balance Sheet
Hansoh Pharmaceutical Group Company Limited has HK$27.12B in cash and marketable securities with HK$116.86M in debt, giving a net cash position of HK$27.00B billion.
Cash & Marketable SecuritiesHK$27.12B
Total DebtHK$116.86M
Net CashHK$27.00B
Net Cash Per ShareHK$4.46
Tangible Book Value Per ShareHK$4.79
Margins
Gross margin is 90.84%, with operating margin of 32.88%, and net profit margin of 35.66%.
Gross Margin90.84%
Operating Margin32.88%
Pretax Margin41.48%
Net Profit Margin35.66%
EBITDA Margin34.89%
EBIT Margin31.83%
Analyst Forecast
The average price target for Hansoh Pharmaceutical Group Company Limited is HK$43.91, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$43.91
Price Target Upside27.05% Upside
Analyst ConsensusStrong Buy
Analyst Count17
Revenue Growth Forecast8.68%
EPS Growth Forecast0.82%